Introduction to Graph Machine Learning
More from the blog
Transfer learning for genomic prediction in underrepresented populations
General Science
Mapping global methane emissions from space with deep learning
Climate & Sustainability
Looking beyond natural sequences
A new machine-learning framework aims to improve the success rate of computational protein design while moving away from results that reproduce sequences found in nature.
Generating scenarios for extreme events, without extreme data
A new algorithm learns to anticipate the unprecedented scenarios that critical infrastructure and global supply chains are least prepared for.
Related papers
Integration of molecular coarse-grained model into geometric representation learning framework for protein-protein complex property prediction
Structure-based machine learning algorithms have been utilized to predict the properties of protein-protein interaction (PPI) complexes, such as binding affinity, which is critical for understanding biological mechanisms and disease treatments. While most existing algorithms represent PPI complex graph structures at the atom-scale or residue-scale, these representations can be computationally expensive or may not sufficiently integrate finer chemical-plausible interaction details for improving predictions. Here, we introduce MCGLPPI, a novel geometric representation learning framework that combines graph neural networks (GNNs) with the MARTINI molecular coarse-grained (CG) model to predict overall PPI properties accurately and efficiently. This framework maps proteins onto a concise CG-scale complex graph, where nodes represent CG beads and edges encode chemically plausible interactions. The GNN-based encoder is tailored to extract high-quality representations from this graph, efficiently capturing the overall properties of the protein complex structure. Extensive experiments on three different downstream PPI property prediction tasks demonstrate that MCGLPPI achieves competitive performance compared with the counterparts at the atom- and residue-scale, but with only a third of the computational resource consumption. Furthermore, the CG-scale pre-training on protein domain-domain interaction structures enhances its predictive capabilities for PPI tasks. MCGLPPI offers an effective and efficient solution for PPI overall property predictions, serving as a promising tool for the large-scale analysis of biomolecular interactions.
PepPCBench is a Comprehensive Benchmarking Framework for Protein-Peptide Complex Structure Prediction
Accurate modeling of protein-peptide interactions is essential for understanding fundamental biological processes and designing peptide-based drugs. However, predicting the complex structures of these interactions remains challenging, primarily due to the high conformational flexibility of peptides. To support a fair and systematic evaluation of recent deep learning (DL) approaches, we introduce PepPCBench, a benchmarking framework tailored to assess protein folding neural networks (PFNNs) in protein-peptide complex prediction. As part of this framework, we curated PepPCSet, a data set of 261 experimentally resolved complexes with peptides ranging from 5 to 30 residues. We benchmark five full-atom PFNNs, including AlphaFold3 (AF3), AlphaFold-Multimer (AFM), Chai-1, HelixFold3 (HF3), and RoseTTAFold-All-Atom (RFAA), using comprehensive evaluation metrics. Our benchmarking reveals meaningful performance differences among these methods and highlights the influence of peptide length, conformational flexibility, and training set similarity on prediction accuracy. While AF3 shows strong performance in structure prediction, further analysis indicates that confidence metrics correlate poorly with experimental binding affinities, underscoring the need for improved scoring strategies and generalizability. By providing a reproducible and extensible framework, PepPCBench enables a robust evaluation of PFNN-based methods and supports their continued development for peptide-protein structure prediction.
Unified and explainable molecular representation learning for imperfectly annotated data from the hypergraph view
Molecular representation learning (MRL) has shown promise in accelerating drug development by predicting chemical properties. However, imperfectly annotation among datasets pose challenges in model design and explainability. In this work, we formulate molecules and corresponding properties as a hypergraph, extracting three key relationships: among properties, molecule-to-property, and among molecules, and developed a unified and explainable multi-task MRL framework, OmniMol. It integrates a task-related meta-information encoder and a task-routed mixture of experts (t-MoE) backbone to capture correlations among properties and produce task-adaptive outputs. To capture underlying physical principles among molecules, we implement an innovative SE(3)-encoder for physical symmetry, applying equilibrium conformation supervision, recursive geometry updates, and scale-invariant message passing to facilitate learning-based conformational relaxation. OmniMol achieves state-of-the-art performance in properties prediction, reaches top performance in chirality-aware tasks, demonstrates explainability for all three relations, and shows effective performance in practical applications. Our code is available in our https://github.com/bowenwang77/OmniMol public repository. AI models for drug discovery often struggle with real-world, incomplete data. Here, the authors present OmniMol, a framework using hypergraphs to improve predictions of molecular properties, addressing challenges of imperfect data annotation and enhancing model explainability.
AntiBMPNN: Structure‐Guided Graph Neural Networks for Precision Antibody Engineering
Antibodies are crucial for medical applications, yet traditional methods for designing sequences are inefficient. This study introduces AntiBMPNN, an advanced deep‐learning framework that leverages an antibody‐specific 3D dataset, a fine‐tuned message‐passing neural network (MPNN), a frequency‐based scoring function, and AlphaFold 3 to achieve highly accurate antibody sequence design. AntiBMPNN surpasses ProteinMPNN with a perplexity of 1.5 and over 80% sequence recovery. Its scoring function, combined with AlphaFold 3, effectively prioritizes sequences based on structural recovery, positional stability, and biochemical or complex properties. Experimental validation highlights a 75% success rate in single‐point antibody design. AntiBMPNN consistently outperforms AbMPNN, AntiFold, and ProteinMPNN in designing complementarity determining regions (CDR) 1‐3, yielding stronger binding affinities. For CDR1 of huJ3 (anti‐HIV nanobody), it achieves a half maximal effective concentration (EC₅₀) of 9.2 nM (nanomolar), better than ProteinMPNN (135.2 nM) and AntiFold (59.3 nM), and comparable to AbMPNN (6.6 nM). For CDR2 of the D6 nanobody (targeting CD16), AntiBMPNN reaches 0.3 nM, outperforming AbMPNN (2.3 nM), AntiFold (0.7 nM), and ProteinMPNN (0.7 nM). In CDR3 of huJ3, it achieves 1.7 nM, surpassing AbMPNN (51.2 nM), with no detectable activity from AntiFold or ProteinMPNN. These findings confirm that AntiBMPNN‐designed sequences for J3 and D6 outperform the originals, highlighting its potential to improve therapeutic antibody design.